{"retracted":false,"update":{"timestamp":1404172800000,"doi":"10.1016/j.injury.2014.03.004","type":"erratum"},"doi":"10.1016/j.injury.2012.08.047","journal":"Injury","publisher":"Elsevier BV","title":"Corrigendum to “The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma” [Injury 44 (2) (2013) 209–216]"}
